First Clinical Use of HAPPE Spine INTEGRATE-C Interbody Fusion

HAPPE Spine announced the first clinical case with the INTEGRATE-C Interbody Fusion System. Full U.S. launch is slated for later in 2023.

Powered by the HAPPE platform, INTEGRATE-C is reported to be the first interbody fusion cage that is fully integrated with porosity and hydroxyapatite to provide a superior healing environment. Interconnected, cancellous porosity promotes bone ingrowth from endplate to endplate. Hydroxyapatite is exposed on all surfaces to promote cell signaling and bone on-growth. INTEGRATE-C is both radiovisible and radiolucent for enhanced intra-operative imaging and post-operative fusion assessment.

This follows FDA 510(k) marketing clearance announced in 2Q23.

Source: HAPPE Spine